After a galley door slammed shut on his right wrist, a 37-year-old deckhand sought medical attention. He had no history of previous injury to the wrist. On examination, he had 50% of normal range of motion, and there was palpable tenderness and bony swelling at the dorsum of the wrist.
After a galley door slammed shut on his right wrist, a 37-year-old deckhand sought medical attention. He had no history of previous injury to the wrist. On examination, he had 50% of normal range of motion, and there was palpable tenderness and bony swelling at the dorsum of the wrist.
An x-ray film (A) was surprising: it showed absence of the navicular bone, secondary degenerative changes primarily in the capitate and lunate bones, extreme atrophy of the radial styloid, and a deformed radial articular surface with an almost transverse orientation of the radiocarpal joint. Normal bone structure is shown for comparison (B).
Absence of the carpal navicular bone is rare. In most of these patients, there are congenital malformations in other body systems as well, and a “VATER” syndrome is found in some.1 This consists of three or more of the following malformations: vertebral defects; anal atresia; tracheoesophageal fistula; and renal and radial dysplasia.
REFERENCE:1. Treble NJ. Congenital absence of the scaphoid in the 'VATER' association. J Hand Surg [Br]. 1985;10:251-252.
Centralizing evidence to boost efficiency across life sciences functions
May 28th 2025The life sciences industry is growing as medtech, biopharma, and investors all face an era of unprecedented innovation and potential. However, firms are also preparing as much as possible for unexpected business challenges and the likelihood of volatility. In an industry that must balance profitability with product efficacy, many life sciences firms are working with new efficiencies to bolster research. In this whitepaper from Wolters Kluwer, you will learn how centralized, unified, and coordinated resources can help organizations overcome fragmented processes and miscommunications, leading to enhanced problem-solving and collaboration, as well as improved outcomes.
Centralizing evidence to boost efficiency across life sciences functions
May 28th 2025The life sciences industry is growing as medtech, biopharma, and investors all face an era of unprecedented innovation and potential. However, firms are also preparing as much as possible for unexpected business challenges and the likelihood of volatility. In an industry that must balance profitability with product efficacy, many life sciences firms are working with new efficiencies to bolster research. In this whitepaper from Wolters Kluwer, you will learn how centralized, unified, and coordinated resources can help organizations overcome fragmented processes and miscommunications, leading to enhanced problem-solving and collaboration, as well as improved outcomes.
2 Commerce Drive
Cranbury, NJ 08512